CClinicalTrials.gg
Status unknownNCT00172913Updated Sep 15, 2005

Aberration-Free Refraction Correction

An observational study in Myopia, sponsored by National Taiwan University Hospital. Status unknown at 1 site in Taiwan. Open to participants aged 0 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2005-09-15.

Sponsored by National Taiwan University Hospital · Observational

The sponsor has not verified this record recently (last verified Jun 2005), so the status shown — last known as Recruiting — may be out of date.
Study type
Observational
Model
Defined population
Time perspective
Other
Enrollment
60
Ages
0 Years and older
Sex
All
01

Study summary

In the interest of improving visual quality after LASIK we have designed a multifaceted study to test the theoretical, physical, biomechanical and functional effects of commercial and independently designed aspherical ablation profiles.

Read the detailed description

The quality of an image on the retina is determined by the optical system of the eyeball, which is dominated by the refractive contribution of the optically powerful cornea. The large difference in refractive index between air and the cornea is the basis for anterior corneal refractive surgery such as Laser in situ Keratomileusis (LASIK) which reshapes the naturally aspherical cornea to correct a patient's vision. In addition to correcting refractive errors, current spherical LASIK treatments have been shown to increase ocular wavefront aberrations which can reduce visual quality postoperatively. Modifications of the corneal-ablation algorithm have been suggested to correct this issue.

Until recently, most ablation algorithms have relied on the Munnerlyn formula, which assumes the anterior corneal surface to be spherical before and after refractive surgery. One concept for customized ablation is to apply an ablation during the surgical procedure which has been adapted to the patient's own aberration pattern. Since custom ablation algorithms are proprietary and we do not know how they consider the role of asphericity.

Precisely altering the corneal asphericity after refraction surgery is a complex phenomenon which includes biomechanical effects. Thus, knowledge of the cornea's response to the different aspherical ablation profiles is vital for understanding corneal properties and prediction of surgical outcomes.

This study will involve computer simulation of ablation profiles for the respective lasers, interferometric analysis of actual ablation profiles on PMMA plates, optimization for visual correction, functional studies of the short and long term effects of the profiles on in vivo human corneas, and quantitative subjective (questionnaire and visual tests) and objective analysis (calculation of retinal image quality metrics) and comparison of the effects aspherical ablation profiles on visual quality. The completion of the project will lead to objective evaluation of current ablation profiles as well as the development and evaluation of new optimized laser refractive surgery procedures with improved outcomes.

02

Conditions studied

  • Myopia

Browse trials for

Keywords

  • Wavefront Aberration
  • LASIK
  • Contrast Sensitivity
  • Visual Performance
  • Ablation Profile
03

In context

Myopia

984 studies on the registry are indexed under Myopia; 210 are open to participants now.

This study's enrollment of 60 is below the median of 150 across 173 observational studies indexed under Myopia.

Browse Myopia studies →

Lead sponsor

National Taiwan University Hospital is the lead sponsor of 2,563 studies on the registry; 569 are open to participants now.

Of its 11 completed or terminated interventional studies of FDA-regulated products, 2 (18%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
0 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • This will be a prospective study including at least 60 patients. The initial study group will include 6-10 patients. Both eyes of enrolled patients should be included in the study unless exclusion criteria prevent it. The primary efficacy variables for this study are wavefront error, visual acuity, autorefraction and contrast sensitivity. Subjects will be followed over a 3 month period. A proposed examination schedule is listed in Table 1.

Eyes will also be divided into groups by refractive error: Low myopia 0-3D, moderate myopia 3-6D, and high myopia 6-9 D and very high myopia > 9D MSRE. The size of the Optical Zone and Transitional Zone is measured, and results are compared for patients of similar refractive error (+/- 0.5 S +/- 0.5 C). Analysis is carried out using a matrix analysis of the total refractive error, comparison of Visual Acuity, Contrast Sensitivity and Responses on a Questionnaire to assess the patient's quality of vision.

Equal numbers of eyes from each of the four refractive error groups and from each of the three treatment groups (OATZ profile 5, OATZ profile 6, conventional) will be measured.

We will consider patients operated on by the same doctor (Dr. Lin). We will also compare treatments of patients and wavefront maps of patients who have similar spherical and cylindrical refractive errors.

Table 1. Examination Schedule (Definitions) Visit Time Preoperative Within 30 days of surgery Operative Day Day of surgery

1 Month postop 3-5 weeks following surgery 3 Months postop 10-14 weeks following surgery

Exclusion criteria

Exclusion Criteria:

  • Patients will be excluded if they have a history of ocular pathology, previous ocular surgery, thin corneas (preoperatively calculated minimal residual bed \< 250um) or fit into the group of the usual exclusionary criteria (e.g. irregular astigmatism, asymmetric astigmatism, unstable refraction).

Possible additional exclusion criteria include no previous refractive surgery, no hyperopia, preop BSCVA 20/25 or better, ages from 21-60 years old, astigmatism above 2D, difficult cases and equal numbers of men and women

05

Study design

Observational model
Defined population
Time perspective
Other
Enrollment
60 participants
06

Study locations

1 of 1 sites recruiting
  • National Taiwan University Hospital
    Taipei, Taiwan
    Recruiting
07

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 15, 2005, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
08

Registry details

Key details

Study ID
NCT00172913
Lead sponsor
National Taiwan University Hospital
First posted
Sep 15, 2005
Start date
Jun 2005
Completion
Jul 2008
Last update
Sep 15, 2005

Study contacts

I-Jong Wang, MD, PHD
Contact
ijong@ha.mc.ntu.edu.tw
886-2-23123456 ext. 5729
I-Jong Wang, MD,PHD
principal investigator · National Taiwan University Hospiyal
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Jun 2005. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion